Open Save New
FeedNavigator / National Library of Health Sciences
 
  
Tutkijat / Oulu
AddAla-Kokko, L.
AddAla-Kokko, T(ero)
AddAla-Korpela, M(ika)
AddAlahuhta, S.
AddAlén, M(arkku)
AddAntikainen, R.
AddAnttonen, V(uokko)
AddBiancari, F(austo)
AddBloigu, R(isto)
AddEskelinen, S.
AddFlinkkilä, T(apio)
AddHakkola, J.
AddHallman, M.
AddHartikainen, A(nna)-L(iisa)
AddHausen, H.
AddHautala, N(ina)
AddHautala, T(imo)
AddHeape, A.
AddHerzig, K(arl)-H(einz)
AddHillbom, M.
AddHiltunen, J.K.
AddHörkko, S.
AddHuikuri, H(eikki)
AddHukkanen J(anne)
AddIgnatius, J.
AddIsohanni, M.
AddJaakkola, J.
AddJaakkola, M(aritta) S.
AddJaakola, V-P.
AddJämsä, T(imo)
AddJanhonen, S.
AddJartti, T(uomas)
AddJärvelin, M(arjo)-R(iitta)
AddJokelainen, J(ari)
AddJuffer, A(ndré) H.
AddJunttila, J(uhani)
AddJuvonen, T.
AddKaarteenaho, R(iitta)
AddKajantie, E(ero)*(THL/OY)
AddKarppinen (Koivunen), P(eppi)
AddKarppinen, J(aro)
AddKarttunen, T.J.
AddKeinänen-Kiukaanniemi, S(irkka)
AddKerkelä, R(isto)
AddKesäniemi, Y(rjö) A(ntero)
AddKettunen, J(ohannes)
AddKietzmann, T(homas).
AddKivirikko, K.I.
AddKnuuttila, M.
AddKoivukangas, J.
AddKursula, P(etri)
AddKyngäs, H.
AddLarivaara, P.
AddLarmas, M.
AddLehenkari, P(etri)
AddLehtiö, L(ari)
AddLeppilahti, J.
AddLuukinen, H.
AddMainio A
AddMajamaa, K.
AddMäki, P(irjo)
AddMäkikallio, T(imo) H.
AddMännikkö, M(inna)
AddManninen, A(ki).
AddMartikainen, H(annu)
AddMiettunen, J(ouko)
AddMyllyharju, J(ohanna)
AddMyllylä, R.
AddMyllylä, V.
AddNäyhä, S(imo)
AddNeubauer, P.
AddNieminen, M(iika) T.
AddNieminen, P(entti)
AddNiinimäki, J(aakko)
AddOhukainen, P(auli)
AddOikarinen, A.
AddOikarinen, K.
AddPelkonen, O(lavi)
AddPetäjä-Repo, U.E.
AddPihlajaniemi, T(aina)
AddPirttiniemi, P(ertti)
AddPuistola, U(lla)
AddRajaniemi, H.J.
AddRäsänen, P.
AddRaustia, A.
AddRemes, A(nne)
AddRisteli, J.
AddRistiniemi, J.
AddRuddock, L.W.
AddRuokonen, A.
AddRyynänen, M.
AddSaarakkala, S.
AddSaari, A.
AddSalo, T(uula)
AddSándor, G(eorge) K.
AddSavolainen, E-R.
AddSavolainen, M.J.
AddSavolainen, O.
AddSillanpää, M(ikko).
AddSoininen, R.
AddSorri, M.
AddTaanila, A.
AddTapiainen, T(erhi)
AddTervonen, O(smo)
AddTimonen, M(arkku)
AddTurpeenniemi-Hujanen, T.
AddTuukkanen, J(uha)
AddTuulonen, A.
AddUhari, M.
AddUkkola, O(lavi)
AddUusimaa, J.
AddVainio, O.
AddVainio, S.
AddVäyrynen, J(uha) P.
AddVeijola, J(uha)
AddVeijola, R(iitta)
AddVirokannas, H.
AddVoipio, H(anna)-M(arja)
AddVuolteenaho, O.
AddWeckström, M.
AddWei, GH.
AddWierenga, R.K.
AddWinqvist, R(obert)
AddYlänne, J.
AddYlitalo, K(ari)

Scholar Chart >>



»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:
Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinologyPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Statement on the translocation potential by <em>Pseudomonas chlororaphis</em> MA342 in plants after seed treatment of cereals and peas and assessment of the risk to humansPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Inhibition and induction of CYP enzymes in humans: an updatePelkonen, O(lavi)4 dayssaveRefWorksSFX Info
CYP-associated drug-drug interactions: A mission accomplished?Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on the genotoxic potential of triazine amine (metabolite common to several sulfonylurea active substances)Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Scientific statement on the coverage of bats by the current pesticide risk assessment for birds and mammalsPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Scientific Opinion on the setting of health-based reference values for metabolites of the active substance terbuthylazinePelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Scientific Opinion about the Guidance of the Chemical Regulation Directorate (UK) on how aged sorption studies for pesticides should be conducted, analysed and used in regulatory assessmentsPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Scientific Opinion on the state of the art of Toxicokinetic/Toxicodynamic (TKTD) effect models for regulatory risk assessment of pesticides for aquatic organismsPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Scientific opinion on pesticides in foods for infants and young childrenPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Scientific Opinion on the state of the science on pesticide risk assessment for amphibians and reptilesPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Scientific Opinion of the PPR Panel on the follow-up of the findings of the External Scientific Report 'Literature review of epidemiological studies linking exposure to pesticides and health effects'Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemiaPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Scientific Opinion addressing the state of the science on risk assessment of plant protection products for in-soil organismsPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Validation of in vitro methods for human cytochrome P450 enzyme induction: Outcome of a multi-laboratory studyPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Integration of epidemiological findings with mechanistic evidence in regulatory pesticide risk assessment: EFSA experiencesPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
EditorialPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearancePelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Obfuscating transparency?Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Toxicology Meets Pharmacodynamics and Pharmacokinetics - New Concepts, Models and In Vitro Approaches and ToolsPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Cytochrome P450 Induction and Xeno-Sensing Receptors Pregnane X Receptor, Constitutive Androstane Receptor, Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptorα at the Crossroads of Toxicokinetics and ToxicodynamicsPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Chemical exposure and infant leukaemia: development of an adverse outcome pathway (AOP) for aetiology and risk assessment researchPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Upholding science in health, safety and environmental risk assessments and regulationsPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Cardiac safety of ophthalmic timololPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Response to“The Path Forward on Endocrine Disruptors Requires Focus”Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Tandem mass spectrometric analysis of S- and N-linked glutathione conjugates of pulegone and menthofuran and identification of P450 enzymes mediating their formationPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Metabolism and metabolite profiles in vitro and in vivo of ospemifene in humans and preclinical speciesPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Differentiation-Promoting Medium Additives for Hepatocyte Cultivation and CryopreservationPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Formation of GSH-trapped reactive metabolites in human liver microsomes, S9 fraction, HepaRG-cells, and human hepatocytesPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Drug Metabolism - From In Vitro to In Vivo, From Simple to Complex: Reflections of the BCPT Nordic Prize 2014 AwardeePelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Principles of Pharmacology and Toxicology Also Govern Effects of Chemicals on the Endocrine SystemPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Very low mammographic breast density predicts poorer outcome in patients with invasive breast cancerPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Biotransformation in vitro: An essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity dataPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Reactive metabolites in early drug development: predictive in vitro toolsPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Why is Research on Herbal Medicinal Products Important and How Can We Improve Its Quality?Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principlesPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principlesPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Human variation and CYP enzyme contribution in benfuracarb metabolism in human in vitro hepatic modelsPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Analytical challenges for conducting rapid metabolism characterization for QIVIVEPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Open letter to the European Commission: scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principlesPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Comparative metabolism of benfuracarb in in vitro mammalian hepatic microsomes model and its implications for chemical risk assessmentPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Estimation of health risk by using toxicokinetic modelling: a case study of polychlorinated biphenyl PCB153Pelkonen, O(lavi)4 dayssaveRefWorksSFX Info
Effects of ospemifene on drug metabolism mediated by cytochrome P450 enzymes in humans in vitro and in vivoPelkonen, O(lavi)4 dayssaveRefWorksSFX Info
 XML / RSS feed
report
next »